CIK 0001761612
- Non-accelerated filer
- Smaller reporting company
BICYCLE THERAPEUTICS PLC
Sign in to watch- Ticker
- BCYC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- Operating
- Phone
- +44 1223261503
- Business address
- BLOCKS A & B, PORTWAY BUILDING, GRANTA PARK, GREAT ABINGTON, CAMBRIDGE, United Kingdom, CB21 6GS
- Former names
- BICYCLE THERAPEUTICS Ltd
- 4 Open-market sale CHIEF EXECUTIVE OFFICER sold 7,683 shares at an average $4.94 ($37,964)
- 4 Open-market sale CHIEF SCIENTIFIC OFFICER sold 2,404 shares at an average $4.94 ($11,877)
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Open-market sale CHIEF ACCOUNTING OFFICER sold 2,432 shares at an average $6.64 ($16,147)
- 4 Open-market sale CHIEF TECHNOLOGY OFFICER sold 6,311 shares at an average $6.62 ($41,804)
- 4 Open-market sale CHIEF PROD & SUPPLY CHAIN OFF sold 5,194 shares at an average $6.64 ($34,491)
- 4 Open-market sale CHIEF OPERATING OFFICER sold 6,660 shares at an average $6.63 ($44,127)
- 4 Planned sale Chief Financial Officer sold 7,623 shares at an average $6.62 ($50,489)
- 4 Open-market sale CHIEF EXECUTIVE OFFICER sold 21,314 shares at an average $6.62 ($141,199)
- 4 Grant or award Director acquired 9,500 shares (grant or award)
- 4 Grant or award Director acquired 7,380 shares (grant or award)
- 4 Grant or award Director acquired 3,032 shares (grant or award)
- 4 Grant or award Director acquired 9,500 shares (grant or award)
- 4 Grant or award Director acquired 3,032 shares (grant or award)
- 4 Grant or award Director acquired 9,500 shares (grant or award)
- 4 Grant or award Director acquired 9,500 shares (grant or award)
- 4 Grant or award Director acquired 3,726 shares (grant or award)
- 4 Grant or award Director acquired 38,000 shares (grant or award)
- 4 Open-market sale CHIEF EXECUTIVE OFFICER sold 5,494 shares at an average $8.41 ($46,182)
Page 2 of 16 · 304 filings